US Patent 11001588 Activating pyruvate kinase R and mutants thereof
Patent 11001588 was granted and assigned to FORMA Therapeutics on May, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11001588 Activating pyruvate kinase R and mutants thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
